DXCM - Dexcom Inc
132
$67.27
-$0.39 (-0.576%)
$67.31
$0.04 (0.064%)
Score4.33/5
Price Targets
74.8%
31.3%
2.1%
Most Recent Recommendations
Revenue Estimate
- Past Revenue
- Avg
- High
- Low
EPS Estimate
- Past EPS
- Avg
- High
- Low
Revenue Estimate as % change
| 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
|---|---|---|---|---|---|---|---|---|
| Low | 14.6% | 11.0% | 8.90% | 9.46% | 7.33% | 13.3% | 11.5% | 9.27% |
| Avg | 12.6% | 12.4% | 12.0% | 12.6% | 10.1% | 1.98% | 11.5% | 9.26% |
| High | 14.9% | 14.0% | 13.0% | 13.0% | 10.6% | -3.42% | 11.5% | 9.26% |
EPS Estimate as % change
| 2026 | 2027 | 2028 | 2029 | 2030 | |
|---|---|---|---|---|---|
| Low | 21.4% | 14.7% | 15.0% | 15.6% | 31.7% |
| Avg | 20.9% | 19.4% | 19.6% | 19.0% | 14.9% |
| High | 21.0% | 27.0% | 26.1% | 19.5% | 0.20% |
Recommendation Trends
- Strong Sells
- Sells
- Holds
- Buys
- Strong Buys
Latest Analyst Ratings
Institution | Action | Grade | Old Grade | Date |
|---|---|---|---|---|
| Citigroup | Maintain | Buy | Buy | 2026-03-11 |
| BTIG | Maintain | Buy | Buy | 2026-03-09 |
| BTIG | Maintain | Buy | Buy | 2026-02-25 |
| Truist Securities | Maintain | Buy | Buy | 2026-02-17 |
| Barclays | Maintain | Underweight | Underweight | 2026-02-13 |
| Canaccord Genuity | Maintain | Buy | Buy | 2026-02-13 |
| Wells Fargo | Maintain | Overweight | Overweight | 2026-02-13 |
| Mizuho | Maintain | Outperform | Outperform | 2026-02-13 |
| BTIG | Maintain | Buy | Buy | 2026-02-13 |
| Barclays | Downgrade | Underweight | Equal-Weight | 2026-01-12 |